This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source, including:

- 2022 Supplier Sales and Shares by Segment and Test
- 2022-2027 Volume and Sales Segment Forecasts by Test
- Supplier Strategies and SWOT Analysis
- Instrumentation Pipeline
- Emerging Technologies
- Opportunities for New Analyzers and Consumables
- Market Challenges and Risks

The report provides test volume and sales forecasts by market segment for the following assays:

CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D

The report is available by section, and can be customized to specific information needs and budget.

Rationale

During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.